CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer
Abstract Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer. TNBC patients typically exhibit unfavorable outcomes due to its rapid growth and metastatic potential. Here, we found overexpression of CCN3 in TNBC patients. We identified that CCN3 knockdown diminished c...
Main Authors: | Seogho Son, Hyungjoo Kim, Hogeun Lim, Joo-hyung Lee, Kyung-min Lee, Incheol Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-02-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-05608-3 |
Similar Items
-
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study
by: Linda T. Vahdat, et al.
Published: (2021-05-01) -
The mechanism of Nov (CCN3) function in haematopoiesis
by: Guo, Y
Published: (2012) -
Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
by: Hyungjoo Kim, et al.
Published: (2022-05-01) -
Prognostic Value of GPNMB, EGFR, p-PI3K, and Ki-67 in Patients with Esophageal Squamous Cell Carcinoma
by: Bo Wang, et al.
Published: (2022-01-01) -
Elevated circulating Gpnmb levels are associated with hyperthyroidism
by: Jiayang Lin, et al.
Published: (2020-08-01)